1.
Acta Psychiatr Scand
; 55(2): 116-22, 1977 Feb.
Article
in English
| MEDLINE
| ID: mdl-320830
ABSTRACT
Pipamperone was compared double-blindly with placebo to evaluate its capacity to relieve sleep disorders in 40 depressive inpatients. At the end of the 1-week trial, most of the items relating to sleep disturbances had improved significantly in the 24 patients of the pipamperone group whereas only a few items showed such a change in the control group. On the Hamilton depression scale, improvement in the pipamperone patients was also superior to that in the placebo group as regards the items "depressed mood" and "insight". The adequate median daily dose of pipamperone appeared to be 80 mg (2 tablets).
Subject(s)
Butyrophenones/therapeutic use , Depression/complications , Sleep Wake Disorders/drug therapy , Administration, Oral , Adolescent , Adult , Aged , Butyrophenones/administration & dosage , Clinical Trials as Topic , Depression/drug therapy , Drug Evaluation , Female , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , Sleep Wake Disorders/complications
2.
Acta Psychiatr Scand
; 50(3): 346-53, 1974.
Article
in English
| MEDLINE
| ID: mdl-4609288
Subject(s)
Piperidines/therapeutic use , Schizophrenia/drug therapy , Tranquilizing Agents/therapeutic use , Adult , Aged , Antiparkinson Agents/therapeutic use , Chronic Disease , Clinical Trials as Topic , Drug Evaluation , Drug Therapy, Combination , Female , Haloperidol/therapeutic use , Hospitalization , Humans , Hydrocarbons, Halogenated/therapeutic use , Interview, Psychological , Middle Aged , Placebos , Psychiatric Status Rating Scales , Surveys and Questionnaires , Time Factors , Toluene/therapeutic use
3.
Psychiatr Neurol Neurochir
; 76(4): 251-9, 1973.
Article
in English
| MEDLINE
| ID: mdl-4581374
Subject(s)
Acetylcholine/antagonists & inhibitors , Movement Disorders/drug therapy , Piperidines/therapeutic use , Tranquilizing Agents/adverse effects , Administration, Oral , Adult , Age Factors , Aged , Basal Ganglia Diseases/chemically induced , Basal Ganglia Diseases/drug therapy , Basal Ganglia Diseases/prevention & control , Benzyl Compounds/administration & dosage , Benzyl Compounds/therapeutic use , Clinical Trials as Topic , Dose-Response Relationship, Drug , Evaluation Studies as Topic , Female , Haloperidol/administration & dosage , Haloperidol/adverse effects , Haloperidol/therapeutic use , Humans , Middle Aged , Piperidones/administration & dosage , Piperidones/therapeutic use , Placebos , Tranquilizing Agents/therapeutic use
4.
Psychiatr Neurol Neurochir
; 76(1): 47-59, 1973.
Article
in English
| MEDLINE
| ID: mdl-4699105
Subject(s)
Pimozide/therapeutic use , Schizophrenia/drug therapy , Tranquilizing Agents/therapeutic use , Adult , Aged , Catatonia/drug therapy , Evaluation Studies as Topic , Female , Follow-Up Studies , Humans , Middle Aged , Pimozide/adverse effects , Placebos , Schizophrenia, Disorganized/drug therapy , Schizophrenia, Paranoid/drug therapy , Tranquilizing Agents/adverse effects
5.
Encephale
; 61(3): 265-74, 1972.
Article
in French
| MEDLINE
| ID: mdl-4649752
6.
Psychiatr Neurol Neurochir
; 75(2): 117-27, 1972.
Article
in English
| MEDLINE
| ID: mdl-5030483
Subject(s)
Phenothiazines/therapeutic use , Piperidines/therapeutic use , Schizophrenia/drug therapy , Tranquilizing Agents/therapeutic use , Blood Cell Count , Blood Sedimentation , Body Weight , Chronic Disease , Evaluation Studies as Topic , Female , Humans , Liver Function Tests , Phenothiazines/adverse effects , Piperidines/adverse effects , Tranquilizing Agents/adverse effects
7.
Acta Psychiatr Scand
; 48(4): 315-31, 1972.
Article
in English
| MEDLINE
| ID: mdl-4566564
Subject(s)
Schizophrenia/drug therapy , Tranquilizing Agents/administration & dosage , Administration, Oral , Adult , Aged , Chronic Disease , Clinical Trials as Topic , Delayed-Action Preparations , Evaluation Studies as Topic , Female , Humans , Injections, Intramuscular , Interview, Psychological , Length of Stay , Middle Aged , Occupational Therapy , Piperidines/therapeutic use , Placebos , Psychiatric Status Rating Scales , Schizophrenia/therapy , Surveys and Questionnaires , Tranquilizing Agents/therapeutic use
8.
Psychiatr Neurol Neurochir
; 74(5): 379-89, 1971.
Article
in English
| MEDLINE
| ID: mdl-5138128
Subject(s)
Psychotic Disorders , Schizophrenia/drug therapy , Spiro Compounds/therapeutic use , Tranquilizing Agents/therapeutic use , Adult , Aged , Autistic Disorder , Behavior , Benzyl Compounds/therapeutic use , Catatonia/drug therapy , Chemical Phenomena , Chemistry , Chronic Disease , Cognition , Extrapyramidal Tracts , Female , Hospitalization , Humans , Hydrocarbons, Halogenated/adverse effects , Hydrocarbons, Halogenated/therapeutic use , Injections, Intramuscular , Middle Aged , Motor Activity , Movement Disorders/chemically induced , Parasympatholytics/therapeutic use , Piperidines/administration & dosage , Piperidines/adverse effects , Piperidines/therapeutic use , Psychiatric Status Rating Scales , Pyridones/therapeutic use , Social Behavior , Spiro Compounds/adverse effects , Stereoisomerism , Tranquilizing Agents/administration & dosage , Tranquilizing Agents/adverse effects
9.
Encephale
; 59(5): 479-85, 1970.
Article
in French
| MEDLINE
| ID: mdl-5502304
10.
Hyg Ment
; 57(1): 25-38, 1968.
Article
in French
| MEDLINE
| ID: mdl-4913262
11.
Psychother Psychosom
; 14(1): 66-77, 1966.
Article
in French
| MEDLINE
| ID: mdl-5939241